These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 517324)

  • 1. Possible biochemical basis of memory disorder in Alzheimer's disease.
    Smith CM; Swash M
    Age Ageing; 1979 Nov; 8(4):289-93. PubMed ID: 517324
    [No Abstract]   [Full Text] [Related]  

  • 2. Physostigmine in Alzheimer's disease.
    Smith CM; Swash M
    Lancet; 1979 Jan; 1(8106):42. PubMed ID: 83485
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of physostigmine on constructional and memory tasks in Alzheimer's disease.
    Muramoto O; Sugishita M; Sugita H; Toyokura Y
    Arch Neurol; 1979 Aug; 36(8):501-3. PubMed ID: 508162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of memory processes in Alzheimer's disease with multiple-dose intravenous physostigmine.
    Davis KL; Mohs RC
    Am J Psychiatry; 1982 Nov; 139(11):1421-4. PubMed ID: 6753611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Facilitation of word retrieval in Alzheimer's disease.
    Huff FJ; Spanier C; Protetch J
    Adv Neurol; 1990; 51():61-4. PubMed ID: 2294665
    [No Abstract]   [Full Text] [Related]  

  • 6. [Memory and language disorders in Alzheimer's dementia].
    Eustache F
    Rev Neurol (Paris); 1992; 148(3):184-92. PubMed ID: 1604132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optogenetic stimulation of serotonin nuclei retrieve the lost memory in Alzheimer's disease.
    Bostancıklıoğlu M
    J Cell Physiol; 2020 Feb; 235(2):836-847. PubMed ID: 31332785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Memory encoding processes in mild and severe dementia. Preliminary data.
    Chiacchio L; Trojano L; Orsini A; Grossi D
    Funct Neurol; 1989; 4(4):395-8. PubMed ID: 2620858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropsychological differences between frontotemporal dementia and Alzheimer's disease: a review.
    Harciarek M; Jodzio K
    Neuropsychol Rev; 2005 Sep; 15(3):131-45. PubMed ID: 16328732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In search of the molecular basis of memory loss in Alzheimer disease.
    Ashe KH
    Alzheimer Dis Assoc Disord; 2006; 20(4):200-1. PubMed ID: 17132961
    [No Abstract]   [Full Text] [Related]  

  • 11. Memory loss in Alzheimer's disease: implications for development of therapeutics.
    Gold CA; Budson AE
    Expert Rev Neurother; 2008 Dec; 8(12):1879-91. PubMed ID: 19086882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of strategic encoding on false memory in patients with mild cognitive impairment and Alzheimer's disease dementia.
    Tat MJ; Soonsawat A; Nagle CB; Deason RG; O'Connor MK; Budson AE
    Brain Cogn; 2016 Nov; 109():50-58. PubMed ID: 27643951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Alzheimer's disease. Relationship between time of disease and its staging].
    Facure NO; Castro LA; Menezes MC
    Arq Neuropsiquiatr; 1993 Jun; 51(2):175-8. PubMed ID: 8274076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Everyday Memory Deficits in Alzheimer's Disease].
    Imamura T
    Brain Nerve; 2018 Jul; 70(7):795-802. PubMed ID: 29997275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Not having verbal repetitiveness might increase confidence that cognitive concerns in ageing are not due to Alzheimer's disease.
    Ong KT; Woodward M
    Aust N Z J Psychiatry; 2017 Jul; 51(7):744-745. PubMed ID: 28633572
    [No Abstract]   [Full Text] [Related]  

  • 16. Patterns of verbal memory impairment in dementia. Alzheimer disease versus multinfarctual dementia.
    Parlato V; Carlomagno S; Merla F; Bonavita V
    Acta Neurol (Napoli); 1988 Dec; 10(6):343-51. PubMed ID: 3228013
    [No Abstract]   [Full Text] [Related]  

  • 17. Physostigmine, auditory P300, and Alzheimer's disease.
    Friedman D
    Biol Psychiatry; 1988 Feb; 23(3):321-3. PubMed ID: 3337867
    [No Abstract]   [Full Text] [Related]  

  • 18. Category and attribute knowledge deterioration in Alzheimer's disease.
    Cox DM; Bayles KA; Trosset MW
    Brain Lang; 1996 Mar; 52(3):536-50. PubMed ID: 8653394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurocognitive differential diagnosis of dementing diseases: Alzheimer's Dementia, Vascular Dementia, Frontotemporal Dementia, and Major Depressive Disorder.
    Braaten AJ; Parsons TD; McCue R; Sellers A; Burns WJ
    Int J Neurosci; 2006 Nov; 116(11):1271-93. PubMed ID: 17000529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Memory enhancement with oral physostigmine in Alzheimer's disease.
    N Engl J Med; 1983 Mar; 308(12):720-1. PubMed ID: 6338388
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.